Latin American Multiple Myeloma Registry Study

Criterios de inclusión

• Incident diagnosis of MM between 01 January 2016 and 31 December 2020 (that is the first observed diagnosis noted in the medical charts)
• An informed-consent form (ICF) or participation agreement must be signed before any data are collected only if a waiver is not permissible. For deceased participants who did not provide consent before death, the permission to research on their information should satisfy the local requirements (that each study site's ethics committee and each country's regulatory authority)
• Only with diagnosis of smouldering myeloma between 01 January 2016 and 31 December 2020 in the medical charts